Aquestive Therapeutics Announces Grant of Inducement Awards for Chief Medical Officer

lunes, 9 de marzo de 2026, 4:02 pm ET1 min de lectura
AQST--

Aquestive Therapeutics has granted an inducement award to its Chief Medical Officer, Matthew Greenhawt, under the 2022 Equity Inducement Plan. The award consists of 75,000 Restricted Stock Units and 50,000 non-qualified common stock options. The award was granted to incentivize Dr. Greenhawt's employment with the company. The equity awards will vest over three years and have a term of ten years.

Aquestive Therapeutics Announces Grant of Inducement Awards for Chief Medical Officer

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios